Avanos Medical, Inc. (AVNS): Price and Financial Metrics

Avanos Medical, Inc. (AVNS): $19.13

0.04 (+0.21%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

AVNS Price/Volume Stats

Current price $19.13 52-week high $31.31
Prev. close $19.09 52-week low $17.24
Day low $18.94 Volume 273,000
Day high $19.40 Avg. volume 321,328
50-day MA $19.20 Dividend yield N/A
200-day MA $21.43 Market Cap 883.86M

AVNS Stock Price Chart Interactive Chart >

AVNS POWR Grades

  • Value is the dimension where AVNS ranks best; there it ranks ahead of 88.69% of US stocks.
  • AVNS's strongest trending metric is Value; it's been moving down over the last 26 weeks.
  • AVNS ranks lowest in Momentum; there it ranks in the 24th percentile.

AVNS Stock Summary

  • Of note is the ratio of AVANOS MEDICAL INC's sales and general administrative expense to its total operating expenses; 76.19% of US stocks have a lower such ratio.
  • AVNS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 20.08% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, AVANOS MEDICAL INC is reporting a growth rate of -138.95%; that's higher than merely 9.73% of US stocks.
  • Stocks that are quantitatively similar to AVNS, based on their financial statements, market capitalization, and price volatility, are AQB, NEO, AOUT, KIDS, and CDXC.
  • Visit AVNS's SEC page to see the company's official filings. To visit the company's web site, go to avanos.com.

AVNS Valuation Summary

  • AVNS's price/sales ratio is 1.4; this is 66.67% lower than that of the median Healthcare stock.
  • AVNS's price/sales ratio has moved up 0.3 over the prior 112 months.

Below are key valuation metrics over time for AVNS.

Stock Date P/S P/B P/E EV/EBIT
AVNS 2023-12-29 1.4 0.9 -18.8 -44.0
AVNS 2023-12-28 1.4 0.9 -19.1 -44.5
AVNS 2023-12-27 1.4 0.9 -19.1 -44.5
AVNS 2023-12-26 1.4 0.9 -19.1 -44.6
AVNS 2023-12-22 1.4 0.9 -19.1 -44.6
AVNS 2023-12-21 1.4 0.9 -19.3 -44.9

AVNS Growth Metrics

    Its 3 year net income to common stockholders growth rate is now at 9.41%.
  • The year over year price growth rate now stands at -25.3%.
  • Its 5 year price growth rate is now at -21%.
Over the past 34 months, AVNS's revenue has gone up $106,200,000.

The table below shows AVNS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 820 90.9 50.5
2022-09-30 795.9 109.3 42.9
2022-06-30 777.9 104.1 -7.9
2022-03-31 761.3 92.4 18.6
2021-12-31 744.6 87.3 5.2
2021-09-30 736.2 36.3 -52

AVNS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AVNS has a Quality Grade of C, ranking ahead of 25.13% of graded US stocks.
  • AVNS's asset turnover comes in at 0.446 -- ranking 106th of 186 Medical Equipment stocks.
  • NDRA, NVNO, and BLFS are the stocks whose asset turnover ratios are most correlated with AVNS.

The table below shows AVNS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.446 0.484 -0.090
2021-06-30 0.434 0.490 -0.090
2021-03-31 0.416 0.507 -0.081
2020-12-31 0.409 0.522 -0.061
2020-09-30 0.404 0.548 -0.003
2020-06-30 0.396 0.558 -0.027

Avanos Medical, Inc. (AVNS) Company Bio


Avanos Medical, Inc. (formerly Halyard Health) is focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. The company was founded in 2014 and is based in Alpharetta, Georgia.


AVNS Latest News Stream


Event/Time News Detail
Loading, please wait...

AVNS Latest Social Stream


Loading social stream, please wait...

View Full AVNS Social Stream

Latest AVNS News From Around the Web

Below are the latest news stories about AVANOS MEDICAL INC that investors may wish to consider to help them evaluate AVNS as an investment opportunity.

Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 1, 2023

Avanos Medical, Inc. to Present at the Stifel 2023 Healthcare Conference

Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer, will participate in an analyst-led fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, Nov. 14 at approximately 10:20 a.m. ET.

Yahoo | November 7, 2023

Avanos Medical, Inc. (NYSE:AVNS) Q3 2023 Earnings Call Transcript

Avanos Medical, Inc. (NYSE:AVNS) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Good morning, and welcome to Avanos’ Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I […]

Yahoo | November 5, 2023

Avanos (AVNS) Q3 Earnings Top Estimates, Margins Contract

Despite strength in Avanos' (AVNS) Digestive Health segment, its overall third-quarter results reflect soft performances.

Yahoo | November 2, 2023

Q3 2023 Avanos Medical Inc Earnings Call

Q3 2023 Avanos Medical Inc Earnings Call

Yahoo | November 2, 2023

Read More 'AVNS' Stories Here

AVNS Price Returns

1-mo -0.31%
3-mo -13.67%
6-mo -4.83%
1-year -32.97%
3-year -58.33%
5-year -55.10%
YTD -14.71%
2023 -17.11%
2022 -21.95%
2021 -24.43%
2020 36.14%
2019 -24.76%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!